ScholarLens Back to search
2019•Respiratory MedicineOpen access

Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment

Stefania Cerri, Matteo Monari, Aldo Guerrieri, Pierluigi Donatelli, Ilaria Bassi, Martina Garuti, Fabrizio Luppi, Sara Betti, Gian Piero Bandelli, Marco Carpano, Maria Letizia Bacchi Reggiani, Roberto Tonelli, Enrico Clini, Stefano Nava

Open full text 78 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 78 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Pirfenidone, Nintedanib, Medicine, DLCO, Idiopathic pulmonary fibrosis, Vital capacity, Internal medicine, Pulmonary function testing

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment — Research Paper | ScholarLens